Peer-reviewed veterinary case report
Outcomes for dogs with tracheal collapse treated with medicine
By Congiusta, Michael et al.·Published in Journal of the American Veterinary Medical Association·2021·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Comparison of short-, intermediate-, and long-term results between dogs with tracheal collapse that underwent multimodal medical management alone and those that underwent tracheal endoluminal stent placement.
- Species:
- dog
Plain-English summary
A group of 159 dogs with tracheal collapse (a condition that can cause breathing problems) were treated either with medication alone or with a surgical procedure called stent placement. While the dogs receiving medication showed some improvement initially, their symptoms worsened over time. In contrast, dogs that underwent stent placement had a significantly longer survival time, especially those with severe disease. For dogs with severe tracheal collapse, the average survival was just 12 days with medication, compared to over 3.5 years with the stent. This suggests that stent placement may be a better option for dogs with more serious cases.
People also search for: dog tracheal collapse treatment · stent placement for dogs · breathing problems in dogs · tracheal collapse medication for dogs
Abstract
OBJECTIVE: To compare short-, intermediate-, and long-term results between dogs with tracheal collapse (TC) that received multimodal medical management only and those that underwent tracheal endoluminal stent placement. ANIMALS: 159 dogs with TC that underwent medical management only (MM group; n = 84) or were surgically managed by stent placement (SM group; 75). PROCEDURES: Medical records of dogs with TC that underwent medical management only or stent placement at a referral hospital between September 1, 2009, and August 1, 2018, were reviewed. Data regarding signalment, information relevant to TC, and outcome were extracted from the records and aggregated into short-, intermediate-, and long-term follow-up periods for analysis. Descriptive data and median survival times (MSTs) were compared between the MM and SM groups. RESULTS: Clinical signs of dogs in the MM group generally improved during the short term but regressed and worsened over time. The proportion of dogs with malformation-type TC that underwent stent placement (38/43 [88%]) was significantly greater than the proportion of dogs with traditional-type TC that underwent stent placement (37/107 [35%]). The MST from TC diagnosis was 3.7 years for the MM group and 5.2 years for the SM group. For dogs with severe disease, the MST was 12 days for medically managed dogs and 1,338 days for dogs that underwent stent placement. CONCLUSIONS AND CLINICAL RELEVANCE: Multimodal medical management alleviated clinical signs for months to years in dogs with mild to moderate TC disease, but stent placement should be considered for dogs with severe disease.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/33496623/